UBS analyst Michael Yee reiterated a Neutral rating and $240.00 price target on Abbvie (NYSE: ABBV).The analyst commented, "The co ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE